Lv44
470 积分 2023-04-30 加入
The New Frontier: Merging Molecular Glue Degrader and Antibody–Drug Conjugate Modalities To Overcome Strategic Challenges
10天前
已完结
Molecular glue meets antibody: next-generation antibody–drug conjugates
10天前
已完结
Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond
10天前
已完结
Process Development of Site-Specific Antibody–Drug Conjugates
25天前
已完结
Revealing lncRNA Structures and Interactions by Sequencing-Based Approaches
28天前
已完结
Chemical Biology Approaches toward Precise Structure Control of IgG‐Based Antibody‐Oligonucleotide Conjugates
1个月前
已完结
Dual-payload antibody–drug conjugates: Taking a dual shot
1个月前
已完结
N-Azidoacetylglucosamine (GlcNAz)-Derived Sugar Oxazolines as a New Class of Substrates for Chemoenzymatic Site-Specific Antibody Bioconjugation
1个月前
已完结
Exploring the next generation of antibody–drug conjugates
1个月前
已完结
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
1个月前
已完结
皖公网安备34019202002308
